Split-thickness skin graft donor site dressing: preliminary results of a controlled, clinical comparative study of MEBO and Sofra-Tulle.

A limited clinical trial on split-thickness skin graft donor sites was conducted in 15 consecutive patients to assess the action of MEBO compared with the conventional Sofra-Tulle (Roussel Laboratories Ltd., Uxbridge, UK) split-thickness skin graft donor site dressing used in our service. All patients included in the study were white, with Fitzpatrick skin types II and III (age range, 5–65 years). The same patient as well as the same donor site was used to study MEBO and the control (Sofra-Tulle). Donor sites other than the upper thigh were excluded from the study. Patients requiring thicker skin grafts than the previously set thickness for the study were also excluded.